PIM
ABBV icon

Plato Investment Management’s AbbVie ABBV Stock Holding History

Plato Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Buy
61,586
+5,154
+9% +$1.11M 0.88% 18
2026
Q1 		$12.3M Buy
56,432
+5,811
+11% +$1.29M 0.82% 16
2025
Q4 		$11.6M Sell
50,621
-2,858
-5% -$651K 0.76% 15
2025
Q3 		$12.3M Buy
53,479
+1,325
+3% +$270K 0.83% 15
2025
Q2 		$9.65M Buy
52,154
+410
+0.8% +$76.2K 0.73% 20
2025
Q1 		$11M Sell
51,744
-13,721
-21% -$2.67M 0.92% 16
2024
Q4 		$11.7M Buy
65,465
+4,901
+8% +$901K 0.86% 14
2024
Q3 		$11.9M Buy
60,564
+930
+2% +$174K 0.97% 12
2024
Q2 		$10.2M Buy
59,634
+4,195
+8% +$695K 0.95% 15
2024
Q1 		$10.1M Buy
55,439
+47,466
+595% +$8.18M 1.04% 12
2023
Q4 		$1.24M Buy
+7,973
New +$1.16M 1.52% 10

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Plato Investment Management's ABBV Position: Q2 2026 in Review

Plato Investment Management increased its AbbVie (ABBV) stake by 9.1% in Q2 2026, buying an estimated $1.11M and bringing the position to 61,586 shares worth $15.4M. The position accounts for 0.88% of the portfolio, ranked #18.

Plato Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Plato Investment Management held 61,586 shares of AbbVie worth $15.4M as of Q2 2026.
  • Plato Investment Management bought 5,154 AbbVie shares in Q2 2026, an estimated $1.11M.
  • AbbVie made up 0.88% of Plato Investment Management's portfolio in Q2 2026, its #18 holding.
  • Plato Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.